Chemical Analysis Confirms Ancient Human Remains in Historic Medicinal Mummy Trade

Key facts

Archaeologists and chemical analysts have examined historical specimens of "mummia vera"—the powder and tarry extracts historically sold by European apothecaries to treat ailments ranging from internal hemorrhaging to bone fractures. Reporting by Pien Huang highlights that these investigations applied modern analytical chemistry to verify whether these legacy pharmaceutical supplies were derived from genuine ancient corpses or were fabrications produced by opportunistic merchants. The testing proved that multiple historical samples preserved in medical museums and institutional archives do indeed consist of pulverized, resin-impregnated human biological tissue.

To reach these conclusions, researchers relied on analytical tools such as gas chromatography coupled with mass spectrometry, a method capable of vaporizing and separating organic chemical mixtures into their constituent molecules. By measuring the mass-to-charge ratio of the resulting fragments, scientists can identify specific biomarker compounds associated with mammalian protein breakdown, as well as the unique chemical signatures of plant resins, animal fats, and petroleum-derived bitumen. The presence of degraded human sterols and cellular residues directly intertwined with ancient embalming agents confirmed that genuine mummified bodies were ground down to manufacture European medical supplies.

In tandem with analyzing historical apothecary stocks, researchers investigated the biochemical makeup of the embalming substances themselves. The data show that Egyptian embalmers did not rely on simple desiccants alone. While natural deposits of natron—a naturally occurring mixture of sodium carbonate decahydrate, sodium bicarbonate, sodium chloride, and sodium sulfate—were used to draw water out of soft tissues during the standard 70-day mummification protocol, long-term stabilization required advanced chemical engineering. Embalmers applied complex, heated cocktails of molten beeswax, cedar and pine resins, plant-derived drying oils, and natural asphalt. Laboratory tests demonstrate that these organic coatings created an oxygen-impermeable seal that completely halted microbial colonization and chemical oxidation, allowing both the skeletal frame and soft tissues to survive intact into the modern era.

Why it matters

The chemical validation of medicinal mummy use transforms our understanding of early modern European pharmacology and underscores the scale of archaeological destruction inflicted upon Egyptian burial sites over eight centuries. Historians have long debated the extent to which the "mummia" sold across European cities such as London, Paris, and Venice was genuine or merely fraudulent imitations made from the dried flesh of executed criminals or deceased livestock. Demonstrating that authentic Egyptian remains were systematically ground, traded, and swallowed across the continent provides physical evidence for the widespread practice of medicinal cannibalism in mainstream Western medicine, which persisted well beyond the Renaissance.

Beyond medical history, the chemical analysis of mummy preparations carries immediate value for contemporary conservation science and biomolecular archaeology. Understanding the exact decay-arresting mechanisms developed thousands of years ago provides modern materials scientists with valuable data on how natural lipids, diterpenoids, and triterpenoids degrade over multi-millennial timescales. Museums and heritage institutions that care for thousands of intact and fragmented mummified bodies around the globe depend on this baseline chemical knowledge to design stabilized environmental storage conditions. When conservators understand which chemical bonds in the preservation matrix are vulnerable to ambient relative humidity, microbial re-activation, or light degradation, they can tailor archival environments to halt further deterioration.

Furthermore, the confirmation that legacy pharmacy jars hold authentic human tissue presents profound ethical and legal ramifications for international institutions. When pharmaceutical artifacts are recognized not merely as historic shelf curiosities or herbal compounds, but as actual human remains, museums are legally and ethically obligated to adjust their handling, display, and inventory protocols under cultural stewardship guidelines.

The therapeutic consumption of Egyptian remains originated through a linguistic and pharmacological error that took root during the Middle Ages. The term "mummy" derives from the Persian word *mumiya*, which originally referred to a naturally occurring black mineral asphalt or petroleum pitch that seeped from rock fissures in the mountains of Persia, particularly around the city of Behbehan. Renowned Islamic-era physicians, including Ibn Sina (Avicenna) and Ibn al-Baitar, documented this natural bitumen as a potent topical and internal agent for reducing inflammation, promoting clotting, and healing fractures.

When medieval European translators translated Arabic medical treatises into Latin during the eleventh and twelfth centuries, they encountered descriptions of *mumiya* as a dark, tar-like substance possessing miraculous healing properties. Observing that many excavated Egyptian bodies were coated in blackened, resinous materials that closely resembled rock bitumen, Western physicians and merchants conflated the preservative coating—and eventually the desiccated human bodies themselves—with the rare Persian mineral drug. Within decades, European medical demand had shifted from the geological substance to the physical remains of embalmed Egyptians.

By the fifteenth and sixteenth centuries, a massive commercial supply network linked Egyptian tombs to European apothecaries. Tombs across Saqqara, Thebes, and Alexandria were looted systematically to supply merchants who exported ship loads of entire or dismembered bodies to maritime trade centers such as Alexandria and Venice. Despite warnings from individual physicians—such as French royal surgeon Ambroise Paré in the sixteenth century, who denounced the consumption of ground cadavers as ineffective and nauseating—the trade remained immensely lucrative. When supply outstripped the availability of ancient remains, counterfeit operations emerged in Cairo, Alexandria, and southern Europe, where modern corpses were cured with pitch, sun-dried, and aged artificially to meet market demand.

The commodification of these remains continued through the industrial revolution. Mummies were repurposed not only for apothecary jars but also ground into pigments, most notably the rich brown oil paint known as "mummy brown," which was utilized by European artists until commercial production ceased in the mid-twentieth century due to a lack of available remains. The commercial availability of medicinal mummy powder persisted surprisingly late: the German chemical and pharmaceutical manufacturer Merck listed genuine mummy (*Mumia vera Aegyptica*) in its standard commercial price catalogs as late as the early 1900s, offering it at roughly eight gold marks per kilogram.

Reaction

The application of analytical chemistry to legacy collections is expected to accelerate ongoing reviews within academic and museum communities regarding the ethical curation of human remains. The British Museum, the Wellcome Collection in London, and numerous university anatomy museums across Germany, France, and North America manage historic pharmaceutical jars labeled as *materia medica* that have historically been cataloged alongside mineral and plant specimens rather than as human bodies.

Heritage ethicists, alongside Egypt’s Ministry of Tourism and Antiquities, consistently advocate for acknowledging the human provenance of all such items. Professional archaeological organizations, including the International Council of Museums (ICOM) and the World Archaeological Congress, maintain strict professional codes requiring that human remains be treated with dignity, respect, and clear genealogical or national provenance where possible. As chemical testing converts ambiguous brown powders in apothecary collections into legally recognized human biological tissue, institutions are expected to face renewed calls for inventory reclassifications, the removal of such jars from public display cases, and discussions regarding appropriate repatriation or reburial protocols in coordination with Egyptian authorities.

What we don't know yet

While chemical testing confirms that genuine remains were ground and sold into European apothecaries, researchers cannot yet quantify the precise historical proportion of genuine ancient mummies versus post-medieval counterfeits across surviving museum collections. Early modern documentation indicates that the manufacture of fake mummies using contemporary cadavers was widespread, yet only a small fraction of surviving apothecary vessels have undergone mass spectrometry testing. It remains uncertain whether the prevalence of genuine tissue was higher during early trade phases in the Middle Ages or whether genuine material dominated through the industrial trade of the nineteenth century.

Additionally, scientists are still working to resolve the precise geographical origins of several specialized plant resins identified in embalming matrices. While researchers know that substances like pistacia resin, cedar oil, and beeswax were sourced regionally, certain complex botanical resins require higher-resolution mass spectrometry libraries to map back to specific plant species native to sub-Saharan Africa or South Asia. Determining these exact origins will clarify the full extent of trade connections that supported the Egyptian embalming industry across different dynastic periods.

What to watch

In the near term, scientific journals are expected to publish expanded molecular databases documenting organic residues extracted from historical *materia medica* jars located across European universities and municipal museums. Observers should track whether institutions that confirm the presence of human tissue in their pharmaceutical collections begin formal deaccessioning or reclassification procedures under their respective domestic human tissue acts, such as the United Kingdom's Human Tissue Act 2004.

Furthermore, field excavations in Egypt, particularly around the subterranean embalming workshops identified at Saqqara and Luxor, are yielding specialized ceramic vessels containing residue traces with ancient instructional inscriptions. Watching how chemical profiles from these controlled, newly excavated archaeological workshops align with the profiles found in historical European pharmacy stocks will offer an unprecedented look into how embalming recipes varied by social status, workshop tradition, and chronological era. Any shift in international heritage policies regarding the destructive sampling of these rare residues will also serve as a crucial indicator for the future pace of molecular archaeology.

This report is based on original reporting by Pien Huang.